American Conference Institute’s Hatch-Waxman Series Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers, including Chief IP and very senior IP/Patent counsel from the leading brand name and generic pharmaceutical companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.

Ryan M. Daniel

Chief Patent Counsel
Region North America
Fresenius Kabi USA, LLC

Opening Remarks

September 21, 2022 8:00 am

Guy Donatiello

Senior Vice President, Intellectual Property
Endo Pharmaceuticals (Malvern, PA)

Stephanie Donahue

Senior Director, Patent Litigation
Sanofi (Bridgewater, NJ)

Serena Farquharson-Torres

Executive Director, Assistant General Counsel
Innovation Law
Bristol Myers Squibb

Linda Friedlieb

Division Counsel
AbbVie

Opening Remarks

September 21, 2022 8:00 am

Staci Julie

SVP and Chief IP Counsel
Teva Pharmaceuticals (Horsham, PA)

Andrea Hutchison

Senior Associate General Counsel, IP Litigation
Gilead Sciences (Foster City, CA)
James Leeds

James P. Leeds

Assistant General Patent Counsel
Eli Lilly & Company (Indianapolis, IN)

James Kellerman

Senior Vice President, Intellectual Property
Astellas Pharma US, Inc. (Northbrook, IL)

Josephine Liu, Ph.D., J.D.

Global Head of IP Litigation
Sandoz

Jeffrey N. Myers, Ph.D.

Vice President & Assistant General Counsel
Pfizer Inc (New York, NY)

Mary Morry

Counsel, IP Litigation
Office of the General Counsel
Merck Sharp & Dohme Corp.

Pearl T. L. Siew

Senior Vice President and Head of IP
Design Therapeutics (Carlsbad, CA)

Brian Stone

Associate General Counsel
Global Legal-Regulatory
Viatris
Lars Taavola

Lars P. Taavola

VP, Chief Intellectual Property Counsel
Mallinckrodt Pharmaceuticals (Bedminster, NJ)

Peter Waibel

Head, US Patent Litigation
Novartis Pharmaceuticals Corporation (East Hanover, NJ)

Kevin Zive

Vice President, General Counsel, and Head of Global Intellectual Property
Apotex Inc.

Emeritus Members

Steve Auten

Stephen R. Auten

Partner, Chair of Pharmaceutical & Life Sciences Litigation
Taft Stettinius & Hollister LLP (Chicago, IL)
(Former Vice President, IP, Sandoz, Inc.)

George W. Johnston

Counsel
Gibbons P.C. (Newark, NJ)
(Former Vice President & Chief Patent Counsel, Hoffmann-La Roche)

David H. Silverstein, M.S., J.D.

Partner
Axinn, Veltrop & Harkrider LLP (New York, NY)
(Former Senior Director, Intellectual Property, Par Pharmaceutical, Inc)

Meg Snowden

Shareholder
Margaret M. Snowden, P.C. (San Francisco, CA)
(Former Vice President,, Intellectual Property, Impax Laboratories)
Shashank Upadhye

Shashank Upadhye

Partner
Upadhye Tang LLP (Chicago, IL)
(Former Vice President – Global Intellectual Property, Apotex, Inc.)